TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRAW TRAWS PHARMA

交易中 12-17 11:29:33 EST

1.72

-0.48

-21.82%

最高2.20	最低1.70	成交量364.19万
今开2.19	昨收2.20	日振幅22.71%
总市值1,374万	流通市值1,019万	总股本799.09万
成交额690.10万	换手率61.46%	流通股本592.57万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":1.72,"timestamp":1765988923992,"preClose":2.2,"halted":0,"volume":3641872,"delay":0,"floatShares":5925700,"shares":7990867,"eps":-1.070813,"marketStatus":"交易中","change":-0.48,"latestTime":"12-17 11:29:33 EST","open":2.19,"high":2.1991,"low":1.6994,"amount":6901038.6092544,"amplitude":0.227136,"askPrice":1.76,"askSize":200,"bidPrice":1.7,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-1.070813,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766005200000},"marketStatusCode":2,"adr":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":2.2,"preHourTrading":{"tag":"盘前","latestPrice":2.2,"preClose":2.2,"latestTime":"09:29 EST","volume":944393,"amount":2233494.8280401,"timestamp":1765981799016},"postHourTrading":{"tag":"盘后","latestPrice":2.315,"preClose":2.2,"latestTime":"19:01 EST","volume":5344,"amount":11884.3575,"timestamp":1765929670002},"volumeRatio":100.507152,"impliedVol":1.6331,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TRAW/tweets","defaultTab":"tweets","newsList":[{"id":"1105664831","title":"Traws Pharma Inc：Ratutrelvir展现出与Paxlovid™的显著不同的特征，副作用更少且未出现病毒反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1105664831","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105664831?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:12","pubTimestamp":1765969962,"startTime":"0","endTime":"0","summary":"Traws Pharma Inc：Ratutrelvir展现出与Paxlovid™的显著不同的特征，副作用更少且未出现病毒反弹","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"1177639705","title":"TRAWS PHARMA公布Ratutrelvir与Paxlovid™对比的积极中期临床数据，显示对不适合使用Paxlovid患者的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1177639705","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177639705?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:12","pubTimestamp":1765969951,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA公布Ratutrelvir与Paxlovid™的对比数据，展示其在不适合使用Paxlovid的COVID-19患者中具有积极的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2586287406","title":"Traws Pharma, Inc.盘中异动 早盘急速拉升6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586287406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586287406?lang=zh_cn&edition=full","pubTime":"2025-11-25 23:17","pubTimestamp":1764083863,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日23时17分，Traws Pharma, Inc.股票出现波动，股价大幅拉升6.17%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231743a710ed57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231743a710ed57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2582361182","title":"Traws Pharma, Inc.盘中异动 快速拉升12.25%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582361182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582361182?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:39","pubTimestamp":1762785575,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分，Traws Pharma, Inc.股票出现异动，股价快速拉升12.25%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Cogent Biosciences, Inc.、Inflarx N.V.、Pluri Inc.涨幅较大，Inflarx N.V.、Propanc Biopharma, Inc.、Innate Pharma较为活跃，换手率分别为78.46%、15.30%、8.72%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Cogent Biosciences, Inc.、Pluri Inc.，振幅分别为22.10%、20.18%、20.06%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022393594fb9650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022393594fb9650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"1157882863","title":"Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作，后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1157882863","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157882863?lang=zh_cn&edition=full","pubTime":"2025-10-31 00:00","pubTimestamp":1761840050,"startTime":"0","endTime":"0","summary":"Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作，后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"1184440960","title":"TRAWS PHARMA启动Ratutrelvir二期新冠研究，首位患者已接受给药，预计2025年底公布结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1184440960","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184440960?lang=zh_cn&edition=full","pubTime":"2025-10-14 19:00","pubTimestamp":1760439648,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA启动Ratutrelvir二期新冠研究，首位患者已接受给药，预计2025年底公布结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1119026861","title":"TRAWS PHARMA任命John Leaman医学博士为独立董事，并正式确认两名核心高管职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1119026861","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119026861?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:02","pubTimestamp":1759748565,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA任命John Leaman医学博士为独立董事，并正式确认两名核心高管职务","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2558664872","title":"Traws Pharma, Inc.盘中异动 股价大涨6.67%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558664872?lang=zh_cn&edition=full","pubTime":"2025-08-12 00:08","pubTimestamp":1754928511,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日00时08分，Traws Pharma, Inc.股票出现异动，股价急速拉升6.67%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5806.00%、551.72%、187.82%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000831a4824c9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000831a4824c9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2557357868","title":"Traws Pharma, Inc.盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557357868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557357868?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:15","pubTimestamp":1754662557,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时15分，Traws Pharma, Inc.股票出现波动，股价急速拉升5.56%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808221557973bf3ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808221557973bf3ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2557335033","title":"Traws Pharma, Inc.盘中异动 下午盘急速上涨5.48%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557335033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557335033?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:38","pubTimestamp":1754332737,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时38分，Traws Pharma, Inc.股票出现波动，股价快速上涨5.48%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805023857a474e98f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805023857a474e98f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2556178038","title":"Traws Pharma, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556178038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556178038?lang=zh_cn&edition=full","pubTime":"2025-08-01 22:11","pubTimestamp":1754057474,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日22时11分，Traws Pharma, Inc.股票出现异动，股价快速下跌5.19%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801221114a46ff1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801221114a46ff1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2555261810","title":"Traws Pharma, Inc.盘中异动 股价大涨5.01%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555261810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555261810?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:00","pubTimestamp":1753898417,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时00分，Traws Pharma, Inc.股票出现异动，股价大幅上涨5.01%。截至发稿，该股报1.64美元/股，成交量8.2203万股，换手率1.48%，振幅5.77%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310200179728495a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310200179728495a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2548222500","title":"Traws Pharma, Inc.6月30日成交额为9.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548222500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548222500?lang=zh_cn&edition=full","pubTime":"2025-07-01 14:19","pubTimestamp":1751350783,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，Traws Pharma, Inc.成交额为9.97万美元，成交额较昨日减少5.23%，当日成交量为6.82万股。Traws Pharma, Inc.于2025年6月30日涨3.5%，报1.48美元，该股过去5个交易日跌4.52%，年初至今跌83.33%，过去60日跌36.21%。其候选产品是 Tivoxavir marboxil、Ratutrelvir 和 Narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701141952a4c83ca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701141952a4c83ca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2546857796","title":"Traws Pharma, Inc.6月26日成交额为12.70万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546857796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546857796?lang=zh_cn&edition=full","pubTime":"2025-06-27 14:18","pubTimestamp":1751005103,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日，Traws Pharma, Inc.成交额为12.70万美元，成交额较昨日减少71.89%，当日成交量为9.01万股。Traws Pharma, Inc.于2025年6月26日涨0.7%，报1.43美元，该股过去5个交易日跌13.33%，年初至今跌83.9%，过去60日跌37.83%。其候选产品是 Tivoxavir marboxil、Ratutrelvir 和 Narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627141827a7202447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627141827a7202447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2546429387","title":"Traws Pharma, Inc.6月24日成交额为19.20万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546429387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546429387?lang=zh_cn&edition=full","pubTime":"2025-06-25 14:43","pubTimestamp":1750833797,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Traws Pharma, Inc.成交额为19.20万美元，成交额较昨日减少15.34%，当日成交量为12.37万股。Traws Pharma, Inc.于2025年6月24日跌1.29%，报1.53美元，该股过去5个交易日跌6.13%，年初至今跌82.77%，过去60日跌40.47%。其候选产品是 Tivoxavir marboxil、Ratutrelvir 和 Narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625144325a71c7e04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625144325a71c7e04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2545477005","title":"Traws Pharma, Inc.6月23日成交额为22.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545477005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545477005?lang=zh_cn&edition=full","pubTime":"2025-06-24 14:41","pubTimestamp":1750747314,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Traws Pharma, Inc.成交额为22.68万美元，成交额较昨日减少36.92%，当日成交量为14.10万股。Traws Pharma, Inc.于2025年6月23日跌7.19%，报1.55美元，该股过去5个交易日跌8.28%，年初至今跌82.55%，过去60日跌38.74%。其候选产品是 Tivoxavir marboxil、Ratutrelvir 和 Narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624144159a71ab05e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624144159a71ab05e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2545351100","title":"Traws Pharma, Inc.6月20日成交额为35.96万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545351100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545351100?lang=zh_cn&edition=full","pubTime":"2025-06-21 14:25","pubTimestamp":1750487112,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日，Traws Pharma, Inc.成交额为35.96万美元，成交额较昨日增加242.48%，当日成交量为21.04万股。Traws Pharma, Inc.于2025年6月20日涨1.21%，报1.67美元，该股过去5个交易日跌7.22%，年初至今跌81.19%，过去60日跌36.98%。其候选产品是 Tivoxavir marboxil、Ratutrelvir 和 Narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621142521a715b759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621142521a715b759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2518475278","title":"Traws Pharma, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518475278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518475278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:22","pubTimestamp":1741616551,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时22分，Traws Pharma, Inc.股票出现波动，股价快速跳水5.30%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3401.51%、720.06%、414.27%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc，振幅分别为41.36%、40.24%、39.34%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022223196404282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022223196404282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2517161983","title":"Traws Pharma, Inc.盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161983?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:13","pubTimestamp":1741274023,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时13分，Traws Pharma, Inc.股票出现异动，股价急速上涨5.05%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Plus Therapeutics, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1510.12%、905.97%、76.46%，振幅较大的相关个股有Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Moolec Science Sa C/Wts ，振幅分别为56.82%、44.64%、44.44%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231343963c5603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231343963c5603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2517910578","title":"Traws Pharma, Inc.盘中异动 早盘股价大涨6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910578?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185027,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Traws Pharma, Inc.股票出现波动，股价急速拉升6.69%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为310.54%、251.30%、183.65%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Plus Therapeutics, Inc.、Zura Bio Limited，振幅分别为8.56%、6.59%、5.61%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223027963adbe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223027963adbe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconova.com","stockEarnings":[{"period":"1week","weight":-0.0947},{"period":"1month","weight":0.0138},{"period":"3month","weight":0.1055},{"period":"6month","weight":0.3333},{"period":"1year","weight":-0.5317},{"period":"ytd","weight":-0.7523}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Traws Pharma, Inc.于1998年12月22日在特拉华州注册成立，于1999年1月1日开始运营，是一家临床阶段的生物制药公司，专注于发现和开发治疗癌症的新型小分子候选药物。Traws正在开发用于流感、COVID和其他呼吸道感染的下一代、同类最佳的抗病毒药物，以及用于肿瘤学的narazaciclib。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.122614},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.076386},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.052994},{"month":4,"riseRate":0.25,"avgChangeRate":-0.132766},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.059914},{"month":6,"riseRate":0.75,"avgChangeRate":0.06745},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019463},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.120142},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.103896},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.080722},{"month":11,"riseRate":0.461538,"avgChangeRate":-0.058331},{"month":12,"riseRate":0.307692,"avgChangeRate":0.040061}],"exchange":"NASDAQ","name":"TRAWS PHARMA","nameEN":"TRAWS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TRAWS PHARMA(TRAW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TRAWS PHARMA,TRAW,TRAWS PHARMA股票,TRAWS PHARMA股票老虎,TRAWS PHARMA股票老虎国际,TRAWS PHARMA行情,TRAWS PHARMA股票行情,TRAWS PHARMA股价,TRAWS PHARMA股市,TRAWS PHARMA股票价格,TRAWS PHARMA股票交易,TRAWS PHARMA股票购买,TRAWS PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TRAWS PHARMA(TRAW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}